Naoki Haruyama

560 total citations
30 papers, 402 citations indexed

About

Naoki Haruyama is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Naoki Haruyama has authored 30 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Naoki Haruyama's work include Dialysis and Renal Disease Management (4 papers), Parathyroid Disorders and Treatments (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). Naoki Haruyama is often cited by papers focused on Dialysis and Renal Disease Management (4 papers), Parathyroid Disorders and Treatments (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). Naoki Haruyama collaborates with scholars based in Japan, United States and Italy. Naoki Haruyama's co-authors include Kazuhiko Tsuruya, Takanari Kitazono, Kosuke Masutani, Masahiro Eriguchi, Kunihiko Sakumi, Yusaku Nakabeppu, Kumiko Torisu, Toshiaki Nakano, Akihiro Tsuchimoto and Takaomi C. Saido and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Naoki Haruyama

28 papers receiving 400 citations

Peers

Countries citing papers authored by Naoki Haruyama

Since Specialization

Citations

This map shows the geographic impact of Naoki Haruyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Haruyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Haruyama more than expected).

Fields of papers citing papers by Naoki Haruyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Haruyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Haruyama. The network helps show where Naoki Haruyama may publish in the future.

Co-authorship network of co-authors of Naoki Haruyama

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Haruyama. A scholar is included among the top collaborators of Naoki Haruyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Haruyama. Naoki Haruyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Novel Kidney Failure Prediction Model in Individuals With CKD: Impact of Serum Bilirubin Levels 2024 ·The Journal of Clinical Endocrinology & Metabolism ·Toyoshi Inoguchi, Tasuku Okui, (unknown), (unknown), Masaru Nakayama, Naoki Haruyama, Kunitaka Fukuizumi, Yoshifumi Wakata, Naoki Nakashima	1
2	Association between Hemoglobin A1c and Renal Arteriolar Sclerosis in Subjects Presenting without any Apparent Kidney Dysfunction 2024 ·Journal of Atherosclerosis and Thrombosis ·Yuta Matsukuma, Akihiro Tsuchimoto, Kosuke Masutani, Kenji Ueki, Shigeru Tanaka, Naoki Haruyama, Yasuhiro Okabe, Masafumi Nakamura, Takanari Kitazono, Toshiaki Nakano	1
3	Plasma B-type natriuretic peptide is independently associated with cardiovascular events and mortality in patients with chronic kidney disease 2024 ·Scientific Reports ·(unknown), Naoki Haruyama, Akiko Fukui, Ryota Yoshitomi, (unknown), Masaru Nakayama	2
4	More rapid progression of brain atrophy in patients on peritoneal dialysis compared with hemodialysis: The VCOHP Study 2023 ·Hypertension Research ·Kazuhiko Tsuruya, Hisako Yoshida, Shunsuke Yamada, Naoki Haruyama, Shigeru Tanaka, Akihiro Tsuchimoto, Masahiro Eriguchi, Kiichiro Fujisaki, Kumiko Torisu, Toshiaki Nakano, Kosuke Masutani, Takanari Kitazono	2
5	Association between iron status markers and kidney outcome in patients with chronic kidney disease 2023 ·Scientific Reports ·(unknown), Masaru Nakayama, Naoki Haruyama, Akiko Fukui, Ryota Yoshitomi, Kazuhiko Tsuruya, Toshiaki Nakano, Takanari Kitazono	6
6	Sex differences in the association between urate metabolism and kidney outcomes in patients with chronic kidney disease 2023 ·Clinical and Experimental Nephrology ·Naoki Haruyama, Masaru Nakayama, Akiko Fukui, Ryota Yoshitomi, Kazuhiko Tsuruya, Toshiaki Nakano, Takanari Kitazono	1
7	A high‐fat diet exacerbates the Alzheimer's disease pathology in the hippocampus of the App^{NL−F/NL−F} knock‐in mouse model 2021 ·Aging Cell ·(unknown), (unknown), Nona Abolhassani, Naoki Haruyama, Kunihiko Sakumi, Takashi Saito, Takaomi C. Saido, Yusaku Nakabeppu	28
8	Author Correction: Comparative profiling of cortical gene expression in Alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation 2021 ·Scientific Reports ·Erika Castillo, Julio Leon, (unknown), Nona Abolhassani, Naoki Haruyama, Takashi Saito, Takaomi C. Saido, Masaaki Hokama, Toru Iwaki, Tomoyuki Ohara, Toshiharu Ninomiya, Yutaka Kiyohara, Kunihiko Sakumi, Frank M. LaFerla, Yusaku Nakabeppu	4
9	Subclinical hypothyroidism is independently associated with poor renal outcomes in patients with chronic kidney disease 2021 ·Endocrine ·(unknown), Masaru Nakayama, Yuta Matsukuma, Ryota Yoshitomi, Naoki Haruyama, Akiko Fukui, Toshiaki Nakano, Kazuhiko Tsuruya, Takanari Kitazono	6
10	8-Oxoguanine accumulation in aged female brain impairs neurogenesis in the dentate gyrus and major island of Calleja, causing sexually dimorphic phenotypes 2019 ·Progress in Neurobiology ·Naoki Haruyama, Kunihiko Sakumi, (unknown), Daisuke Tsuchimoto, Gabriele De Luca, Margherita Bignami, Yusaku Nakabeppu	12
11	Comparative profiling of cortical gene expression in Alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation 2017 ·Scientific Reports ·Erika Castillo, Julio Leon, (unknown), Nona Abolhassani, Naoki Haruyama, Takashi Saito, Takaomi C. Saido, Masaaki Hokama, Toru Iwaki, Tomoyuki Ohara, Toshiharu Ninomiya, Yutaka Kiyohara, Kunihiko Sakumi, Frank M. LaFerla, Yusaku Nakabeppu	113
12	Association between serum uric acid level and renal arteriolar hyalinization in individuals without chronic kidney disease 2017 ·Atherosclerosis ·Yuta Matsukuma, Kosuke Masutani, Shigeru Tanaka, Akihiro Tsuchimoto, Naoki Haruyama, Yasuhiro Okabe, Masafumi Nakamura, Kazuhiko Tsuruya, Takanari Kitazono	11
13	Vascular endothelial growth factor-C ameliorates renal interstitial fibrosis through lymphangiogenesis in mouse unilateral ureteral obstruction 2017 ·Laboratory Investigation ·(unknown), Toshiaki Nakano, Kumiko Torisu, Akihiro Tsuchimoto, Masahiro Eriguchi, Naoki Haruyama, Kosuke Masutani, Kazuhiko Tsuruya, Takanari Kitazono	61
14	Subacute pulmonary embolism in a hemodialysis patient, successfully treated with surgical thrombectomy 2016 ·CEN Case Reports ·(unknown), Naoki Haruyama, Masatomo Taniguchi, Takahiro Nishida, Ryuji Tominaga, Takanari Kitazono, Kazuhiko Tsuruya	0
15	Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study 2015 ·PLoS ONE ·Kazuhiko Tsuruya, Hisako Yoshida, Naoki Haruyama, Kiichiro Fujisaki, Hideki Hirakata, Takanari Kitazono	22
16	De novo myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis 31 years after living-donor kidney transplantation 2014 ·CEN Case Reports ·Naoki Haruyama, Akihiro Tsuchimoto, Kosuke Masutani, Hideko Noguchi, Takaichi Suehiro, Hidehisa Kitada, Kazuhiko Tsuruya, Takanari Kitazono	5
17	Protocol Biopsy Findings in Living Donor Kidney Transplant Patients Treated With Once-daily or Twice-daily Tacrolimus Formulation 2014 ·Transplantation Proceedings ·Kosuke Masutani, Akihiro Tsuchimoto, Naoki Haruyama, Hidehisa Kitada, Yasuhiro Okabe, Hiroshi Noguchi, Masatoshi Tanaka, Kazuhiko Tsuruya, Takanari Kitazono	6
18	Renal denervation has blood pressure–independent protective effects on kidney and heart in a rat model of chronic kidney disease 2014 ·Kidney International ·Masahiro Eriguchi, Kazuhiko Tsuruya, Naoki Haruyama, Shunsuke Yamada, Shigeru Tanaka, Takaichi Suehiro, Hideko Noguchi, Kosuke Masutani, Kumiko Torisu, Takanari Kitazono	28
19	Subclinical nephrosclerosis is linked to left ventricular hypertrophy independent of classical atherogenic factors 2013 ·Hypertension Research ·Naoki Haruyama, Akihiro Tsuchimoto, Kosuke Masutani, Masaharu Nagata, Hidehisa Kitada, Masao Tanaka, Kazuhiko Tsuruya, Takanari Kitazono	6
20	Candida glabrata fungemia in a diabetic patient with neurogenic bladder: successful treatment with micafungin 2006 ·Clinical Nephrology ·Naoki Haruyama, Kosuke Masutani, Kazuhiko Tsuruya, (unknown), Jiro Toyonaga, T. Yao, Ken Goto, (unknown), Hiroyuki HIRAKATA, Masakazu Iida	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact